Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy.
|
19799798 |
2009 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
|
9425228 |
1998 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
CausalMutation |
CLINVAR |
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
|
8710906 |
1996 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
|
21150883 |
2011 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom.
|
25780468 |
2014 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
CausalMutation |
CLINVAR |
Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
|
20340136 |
2010 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
|
20340136 |
2010 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
Biomarker |
CLINGEN |
Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
|
20340136 |
2010 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
|
11815963 |
2002 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
Biomarker |
CLINGEN |
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
|
17713536 |
2007 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Mutations in brief no. 148. Online.
|
10627132 |
1998 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
Biomarker |
CLINGEN |
Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
|
8653684 |
1996 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
CausalMutation |
CLINVAR |
Novel CDKN2A mutations in Austrian melanoma patients.
|
26225579 |
2015 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Novel CDKN2A mutation detected in Spanish melanoma pedigree.
|
20653773 |
2010 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
Biomarker |
CLINGEN |
Novel and recurrent p14 mutations in Italian familial melanoma.
|
20132244 |
2010 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
CausalMutation |
CLINVAR |
Mutations associated with familial melanoma impair p16INK4 function.
|
7647780 |
1995 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
CausalMutation |
CLINVAR |
Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma.
|
9916806 |
1999 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
CausalMutation |
CLINVAR |
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
|
26775776 |
2016 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
CausalMutation |
CLINVAR |
MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability.
|
16169933 |
2006 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
Biomarker |
CLINGEN |
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.
|
11544530 |
2001 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
Biomarker |
CLINGEN |
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.
|
22636603 |
2012 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
Improving performance of multigene panels for genomic analysis of cancer predisposition.
|
26845104 |
2016 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
Biomarker |
CLINGEN |
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.
|
7670475 |
1995 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
Biomarker |
CLINGEN |
Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: evidence for common founders and independent mutations.
|
9603434 |
1998 |
Entrez Id: |
1029 |
Gene Symbol: |
CDKN2A |
CDKN2A
|
MELANOMA-PANCREATIC CANCER SYNDROME
|
0.600 |
GeneticVariation |
CLINVAR |
GESPA: classifying nsSNPs to predict disease association.
|
26206375 |
2015 |